News
-
First oral monotherapy for patients with paroxysmal nocturnal haemoglobinuria
-
New antibiotic to fight infections caused by multidrug-resistant bacteria
-
Regulatory information – adjusted fees for applications to EMA from 1 April 2024
-
Decision 9C_562/2023
-
Current legal developments in the healthcare sector
-
Product Recall 2024 - Chapter Switzerland
-
Overview of health insurance figures
-
Accelerating stakeholder collaboration to enhance the clinical trials environment in the EU
-
Extension of the deadline for setting the tariff for outpatient physiotherapy services
-
Decision 2C_537/2022 of 25 January 2024
-
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 March 2024
-
Decision 149 II 381 of 18 September 2023
-
European Court of Justice, Decision C-291/22 P of 14 March 2024
-
Canton of Zurich: Implementation of new admission restrictions suspended for the time being
-
Fennel tea for pregnant women, infants and children under 4 years
-
Swissmedic Journal 02/2024
-
New authorisations of complementary and herbal medicines
-
Public consultation on ICH Guideline E2D(R1) launched in Switzerland
-
DARWIN EU® continues expanding its capacity to deliver real-world data studies
-
Decision C-1664/2019 of 29 January 2024
-
Decision C-271/2021 of 5 February 2024